Yu Qi
Zhongshan, 200032, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Efficient extraction via titanium organic frameworks facilitates in-depth profiling of urinary exosome metabolite fingerprints.
Journal: Analytical and bioanalytical chemistry
Published: December 11, 2024
Artificial intelligence links CT images to pathologic features and survival outcomes of renal masses.
Journal: Nature communications
Published: June 05, 2024
Tumor infiltrating B lymphocytes (TIBs) associate with poor clinical outcomes, unfavorable therapeutic benefit and immunosuppressive context in metastatic clear cell renal cell carcinoma (mccRCC) patients treated with anti-PD-1 antibody plus Axitinib.
Journal: Journal of cancer research and clinical oncology
Published: April 27, 2024
Heterogeneous MXene Hybrid-Oriented Exosome Isolation and Metabolic Profiling for Early Screening, Subtyping and Follow-up Evaluation of Bladder Cancer.
Journal: ACS nano
Published: December 01, 2023
Development and validation of an individualized DNA repair-related gene signature in localized clear cell renal cell carcinoma.
Journal: World journal of urology
Published: February 07, 2020
Relevance of arm somatic copy number alterations for oncologic outcomes and tumor immune microenvironment in clear cell renal cell carcinoma.
Journal: Annals of translational medicine
Published: January 14, 2020
Tumor-infiltrating CD39+CD8+ T cells determine poor prognosis and immune evasion in clear cell renal cell carcinoma patients.
Journal: Cancer immunology, immunotherapy : CII
Published: December 11, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026